Cargando…
A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
PURPOSE: The purpose of this study was to assess the preventive effect of cilostazol on in-stent restenosis in patients after superficial femoral artery (SFA) stent placement. MATERIALS AND METHODS: Of 28 patients with peripheral arterial disease, who had successfully undergone stent implantation, 1...
Autores principales: | Ikushima, Ichiro, Yonenaga, Kazuchika, Iwakiri, Hironao, Nagoshi, Hideki, Kumagai, Haruhito, Yamashita, Yasuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417878/ https://www.ncbi.nlm.nih.gov/pubmed/22915934 http://dx.doi.org/10.2147/MDER.S21629 |
Ejemplares similares
-
Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012) -
Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018) -
Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
por: Tobita, Kazuki, et al.
Publicado: (2023) -
Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry
por: Vu, Michael H., et al.
Publicado: (2022) -
Comparison of cilostazol versus ticlopidine following coronary stenting in patients with coronary heart disease: A meta-analysis of randomized controlled trials
por: HU, FENG-HUAN, et al.
Publicado: (2013)